NANO....... Kursen går opp og ned. Hvor lenge skal dette pågå ?
Fra Internett
So the use of proceeds is going to be spent on the manufacturing development activities. We are moving into filing and also launch. And as you know, the process to produce Betalutin is a total different ballgame to produce for clinical trial compared to produce when you're moving into the market. So that's why we're spending money here. And we also are scaling up clinical and commercial activities, so we can prepare and be ready to launch Betalutin when we have got the regulatory approval.
During the visit, Bjørn Pedersen, our Managing Director gave the minister a tour of our facility. The minister paid close attention when Bjørn explained the technology we use to produce monoclonal antibodies. The antibodies are used for diagnostics and cancer treatment. Bjørn could proudly inform the Minister that Diatec Monoclonals are aiming to be FDA approved for commercial production of biologics, within 2020. This is a fist in Norway !
So the use of proceeds is going to be spent on the manufacturing development activities. We are moving into filing and also launch. And as you know, the process to produce Betalutin is a total different ballgame to produce for clinical trial compared to produce when you're moving into the market. So that's why we're spending money here. And we also are scaling up clinical and commercial activities, so we can prepare and be ready to launch Betalutin when we have got the regulatory approval.
During the visit, Bjørn Pedersen, our Managing Director gave the minister a tour of our facility. The minister paid close attention when Bjørn explained the technology we use to produce monoclonal antibodies. The antibodies are used for diagnostics and cancer treatment. Bjørn could proudly inform the Minister that Diatec Monoclonals are aiming to be FDA approved for commercial production of biologics, within 2020. This is a fist in Norway !
Redigert 20.01.2021 kl 13:24
Du må logge inn for å svare
Frontmasta
28.03.2019 kl 20:20
4000
Vet dere noe om hvorfor Ramdahl tar på seg styreverv i Australia ????????
..........Clarity develops its drug pipeline by in-licensing promising biological molecules, such as peptides, proteins, antibody fragments or antibodies, and progressing these to create therapeutic products and companion diagnostics for the treatment of serious diseases such as cancer, cardiovascular disease and fibrosis.........
Nordic Nanovecter.......We are putting in place key elements for its commercialisation pending approval.
..........Clarity develops its drug pipeline by in-licensing promising biological molecules, such as peptides, proteins, antibody fragments or antibodies, and progressing these to create therapeutic products and companion diagnostics for the treatment of serious diseases such as cancer, cardiovascular disease and fibrosis.........
Nordic Nanovecter.......We are putting in place key elements for its commercialisation pending approval.
Redigert 28.03.2019 kl 20:26
Du må logge inn for å svare
Frontmasta
28.03.2019 kl 21:06
3892
Radioimmunotherapy Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024” reports to its database
Summary
Radioimmunotherapy Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report
This report provides in depth study of “Radioimmunotherapy Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Radioimmunotherapy Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.
This report focuses on the global Radioimmunotherapy,, and the key players covered in this study
Bayer Healthcare Pharmaceuticals
BioSynthema
Clarity Pharmaceuticals
Curasight
Endocyte
Immunomedics
Molecular Insight Pharmaceuticals
Nordic Nanovector
PDL Biopharma
Philogen
RadioMedix
Stella Pharma
Telix Pharmaceuticals
https://gust.com/companies/clarity_pharmaceuticals
Hva finner man så om Ramdahl på nettet...........
Summary
Radioimmunotherapy Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report
This report provides in depth study of “Radioimmunotherapy Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Radioimmunotherapy Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.
This report focuses on the global Radioimmunotherapy,, and the key players covered in this study
Bayer Healthcare Pharmaceuticals
BioSynthema
Clarity Pharmaceuticals
Curasight
Endocyte
Immunomedics
Molecular Insight Pharmaceuticals
Nordic Nanovector
PDL Biopharma
Philogen
RadioMedix
Stella Pharma
Telix Pharmaceuticals
https://gust.com/companies/clarity_pharmaceuticals
Hva finner man så om Ramdahl på nettet...........
Redigert 28.03.2019 kl 21:14
Du må logge inn for å svare
Frontmasta
30.03.2019 kl 20:14
3486
From Internettpages in US
Hematological cancer specialist Nordic Nanovector want partner deal before they send new paper to FDA late in 2019
Hematological cancer specialist Nordic Nanovector want partner deal before they send new paper to FDA late in 2019
Frontmasta
30.03.2019 kl 22:16
3310
Horn media.
Nordic Nanovector intends to commercialise its product candidates through strategic alliances and partnerships with experienced oncology businesses and by establishing its own sales and marketing capabilities in selected markets.
Bravo........
Nordic Nanovector intends to commercialise its product candidates through strategic alliances and partnerships with experienced oncology businesses and by establishing its own sales and marketing capabilities in selected markets.
Bravo........
Kappa3278
30.03.2019 kl 22:20
3299
Og linken til dette finner vi hvor masta?
"Hematological cancer specialist Nordic Nanovector want partner deal before they send new paper to FDA late in 2019"
"Hematological cancer specialist Nordic Nanovector want partner deal before they send new paper to FDA late in 2019"
Frontmasta
30.03.2019 kl 22:42
3257
Kappa
Her hos Trygve er det ingen som har meldt seg på nyhetsbrev om NN som publiseres i USA. Enkelt og kostnadsfritt. Husk at Nordic Nanovecter må sende inn data hver 3 måned for alle studier etter at de fikk PIM og FAST TRACK.
Etter at NN fikk fast i USA må søknad om full godkjennelse sendes inn lenge før alle avlesningene for Lymrit 37/ 01 er avsluttet i 2025
Hvorfor skal en norman i styret tili et Australsk medesinselskap som har kontorer i hele verden,til og med der hvor Bravo holder til........
Her hos Trygve er det ingen som har meldt seg på nyhetsbrev om NN som publiseres i USA. Enkelt og kostnadsfritt. Husk at Nordic Nanovecter må sende inn data hver 3 måned for alle studier etter at de fikk PIM og FAST TRACK.
Etter at NN fikk fast i USA må søknad om full godkjennelse sendes inn lenge før alle avlesningene for Lymrit 37/ 01 er avsluttet i 2025
Hvorfor skal en norman i styret tili et Australsk medesinselskap som har kontorer i hele verden,til og med der hvor Bravo holder til........
Redigert 30.03.2019 kl 23:01
Du må logge inn for å svare
Kappa3278
30.03.2019 kl 22:51
3247
Masta, du skriver følgende....
"From Internettpages in US", altså om denne ligger på Internett finnes det en link......
Hvor er linken, kan du vennligst svare på det jeg spør om?
"From Internettpages in US", altså om denne ligger på Internett finnes det en link......
Hvor er linken, kan du vennligst svare på det jeg spør om?
New2As
30.03.2019 kl 23:24
3188
Hehe, hvis det er ment som et sitat så er dette i følge internettet en såkalt bløff. Det kan derimot se ut som et kreativt sammendrag av en (gammel) invent artikkel :)
Har du en slik URL ?
Har du en slik URL ?
Frontmasta
30.03.2019 kl 23:28
3183
Kappa
I min mappe for NN har jeg nå lagret 17347 forskjellige linker, men må desverre bruke briller x 4. Jeg skal nok klare å finne linken som viser at FDA forlanger at NN sender inn søknaden " full godkjenning" innen 2019
I min mappe for NN har jeg nå lagret 17347 forskjellige linker, men må desverre bruke briller x 4. Jeg skal nok klare å finne linken som viser at FDA forlanger at NN sender inn søknaden " full godkjenning" innen 2019
Frontmasta
30.03.2019 kl 23:39
3166
Man flyttes over fra den vanlige køen til et felt med mindre hindringer, og har da en fortløpende dialog med FDA ettersom studien går, i motsetning til å måtte sende resultatene når alt er ferdig, sier Einarson
n4479556
31.03.2019 kl 01:17
3096
Er det kanskje denne: https://www.diatec.com/torbjorn-roe-isaksen-visits-diatec-monolconals/
focuss
31.03.2019 kl 20:37
2504
Link eller ikke link så er det vel som forventet at det er ønskelig med partner i Europa. At FDA forventer søknad i 2019 er vel ikke hva markedet forventer.